Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
RNA Modification
100%
Cardiac Arrest
100%
Neurological Outcome
56%
N1-methyladenosine
47%
Epitranscriptomics
47%
Cerebral Performance Category
45%
Outcome Prediction
40%
Regulatory Role
37%
Neurological Death
33%
Solute Carrier Family 2 Member 1
33%
Pathological Cardiac Remodeling
33%
Direct RNA Sequencing
33%
Vascular Disease
33%
RNA Editing
33%
Acute Coronary Syndrome
33%
RNA Splicing
33%
Proteomic Biomarkers
33%
Peripheral Blood
33%
M6Am
33%
Circular RNA
33%
ST-elevation Myocardial Infarction (STEMI)
33%
Neurological Sequelae
27%
Angina Pectoris
23%
SLC2A1
19%
North Pole
14%
Omics Data
13%
Survivors
13%
Return of Spontaneous Circulation
13%
Cardiac Arrest Survivors
11%
Cardiac Remodeling
11%
Heart Failure
11%
High-throughput Gene Expression
11%
Medicine Discovery
11%
Transcriptome Complexity
11%
RNA Isoforms
11%
Heart Function
10%
Pseudouridine
10%
N6-methyladenosine
10%
Disease Progression
9%
High-sensitivity C-reactive Protein (hs-CRP)
9%
Brain Injury
9%
Glucose Transporter 1 (GLUT1)
9%
Quantitative PCR
9%
Causes of Mortality
8%
Post-cardiac Arrest
8%
Blood Levels
8%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
8%
Whole Blood Sample
8%
95% Confidence Interval
8%
Multivariable Logistic Regression
8%
Biochemistry, Genetics and Molecular Biology
RNA Modification
73%
Cardiac Arrest
66%
RNA Sequence
66%
Epitranscriptomics
42%
Solute Carrier Family
33%
RNA Splicing
33%
Transcriptomics
33%
ST Elevation
33%
Tamsulosin
22%
RNA
16%
Gene Expression
12%
Molecular Mechanism
12%
Morbidity
11%
Real-Time Polymerase Chain Reaction
11%
Isoform
11%
N6-Methyladenosine
10%
Pseudouridine
10%
Biomarker Discovery
6%
Gene Expression Profiling
6%
Bulk RNA Sequencing
6%
Post-Transcriptional Regulation
6%
Spatial Transcriptomics
6%
Transcriptome
6%
Blood Level
5%
Return of Spontaneous Circulation
5%
GLUT1
5%
Blood Brain Barrier
5%
Glucose Transporter
5%
Upregulation
5%
Blood Flow
5%
Heart Function
5%
Artificial Intelligence
5%
Post-Transcriptional Process
5%
Metabolomics
5%
Gene Control
5%
Macrophage
5%
Cell Function
5%
Lipid Metabolism
5%
RNA Stability
5%
Genomics
5%
RNA Editing
5%
Proteomics
5%
MicroRNA
5%
5-Methylcytosine
5%
Alternative Splicing
5%
Prognostic Biomarker
5%
Omics Approaches
5%
